X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-06-20 | PSEC | Prospect Capital Corp | Barry John F | CEO, 10% | P - Purchase | $3.19 | +623,300 | 83,622,108 | +1% | +$1,988,763 | ||||||
| M | 2025-06-20 | IMRX | Immuneering Corp | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | P - Purchase | $2.58 | +13,422 | 359,318 | +4% | +$34,616 | |||||
2025-06-24 | RZLT | Rezolute, Inc. | Evans Daron | CFO | P - Purchase | $4.05 | +5,000 | 360,900 | +1% | +$20,250 | ||||||
2025-06-20 | AKTX | Akari Therapeutics Plc | Gaslightwala Abizer | Pres, CEO | P - Purchase | $1.20 | +10,000 | 271,428 | +4% | +$12,000 | ||||||
| M | 2025-06-20 | MDBH | Mdb Capital Holdings, LLC | Marlett Christopher A | Co-Founder, 10% | P - Purchase | $4.13 | +1,565 | 144,235 | +1% | +$6,457 | |||||
2025-06-20 | IMRX | Immuneering Corp | Brakewood Harold Eugene | Chief Business Officer | P - Purchase | $2.53 | +1,900 | 5,800 | +49% | +$4,804 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |